{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-000252","form_type":"8-K","ticker":"BDPT","cik":"0001575142","company_name":"BIOADAPTIVES, INC.","filed_at":"2022-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.142370+00:00","generated_at":"2026-06-27T11:42:02.420887+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioAdaptives acquires exclusive option to buy oxygenated-water patent, forms MORO2 subsidiary","bullets":["Exclusive two-year option to purchase U.S. Patent 9,783,432B for $400,000.","Exclusive two-year license to use technology for developing oxygenated water products.","Wholly-owned subsidiary MORO2, Inc. formed to exploit the patent and tech.","Inventor Thomas J. Mohr to provide consulting services and assist in product development.","Company plans to start marketing efforts during 2Q 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-000252","json":"https://secwatch.observer/filing/0001640334-22-000252.json","markdown":"https://secwatch.observer/filing/0001640334-22-000252.md","text":"https://secwatch.observer/filing/0001640334-22-000252.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1575142/000164033422000252/0001640334-22-000252-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1575142/000164033422000252/bdpt_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T11:42:02.420887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}